FIAPro™ Hormone Detection Platform

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.

CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.

A next-generation diagnostic platform using high-frequency SH-SAW sensor technology to detect biomarkers for heart disease, inflammation, and cancer. The platform processes 5 μL of whole blood without red blood cell interference and delivers results in under 3 minutes.

A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.

Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.

Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.

An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

A dry-phase fluorescent immunoassay detection platform for in vitro diagnostic testing. The analyzer provides rapid results with high sensitivity and is designed for point-of-care applications across multiple clinical disciplines.